ALSO NOTED: Sanofi still bullish on Lovenox; scientists engineer schizophrenic mice;and much more...

> Hit by heightened generic competition, Sanofi says that Lovenox should remain a bestseller. Report

> The EMEA has recommended that Astion Pharma's ASF-1096 be granted orphan drug status for the treatment of "Cutaneous Lupus Erythematosus." Release

> GSK China and Sinovac have struck a deal to market and promote Anflu, a seasonal influenza vaccine developed and manufactured by Sinovac. Release

> Scientists at Johns Hopkins have genetically engineered mice to carry a human gene that triggers schizophrenia, an advance that will help researchers search for new methods to control the disease. Report

> GeoVax has inked a $7.5 million private placement deal. Release

> A study by the California Department of Public Health has determined that women exposed to high levels of a certain type of pesticide were up to six times more likely to give birth to autistic children. Report

And Finally... New therapies for dogs are helping boost Pfizer's top line. Report